| Structure | Chemical Name | CAS | MF |
|
S,S'-TRIMETHYLENEBIS(PHENYLMETHANETHIOSULFONATE)
|
|
C17H20O4S4
|
|
(8S,10S)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-10-[(2S,4S,5S,6S)-5-hydroxy-6-methyl-4-morpholin-4-yl-oxan-2-yl]oxy-1-methoxy-9,10-dihydro-7H-tetracene-5,12-dione hydrochloride
|
89196-04-3
|
C31H36ClNO12
|
|
(1S,6S)-2,7,7-TRIMETHYL-3-OXA-TRICYCLO[4.1.1.0(2,4)]OCTANE
|
|
C10H16O
|
|
(8S,10S)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-10-[5-hydroxy-4-[(2S)-2-methoxymorpholin-4-yl]-6-methyl-oxan-2-yl]oxy-1-methoxy-9,10-dihydro-7H-tetracene-5,12-dione
|
108943-08-4
|
C32H37NO13
|
|
(1S,4S)-2-(4-Trifluoromethylbenzyl)-2,5-diaza-
|
|
|
|
|
(1s,4s)-(+)-2-(3-trifluoromethyl-benzyl)-2,5-diaza-bicyclo[2.2.1]heptane
|
|
|
|
|
(1S,4S)-(+)-2-(3-TRIFLUOROMETHYL-BENZYL)-2,5-DIAZA-BICYCLO[2.2.1]HEPTANE 2CF3COOH
|
|
|
|
|
(S,S)-3,4,5-TRIFLUOROPHENYL-NAS BROMIDE
|
287384-12-7
|
C56H34BrF6N
|
|
(1S,4S)-(+)-2-(4-TRIFLUOROMETHYL-BENZYL)-2,5-DIAZA-BICYCLO[2.2.1]HEPTANE 2CF3COOH
|
845866-70-8
|
C17H17F9N2O4
|
|
|
(6S,17S)-10,13,17-trimethyl-6,17-bis(trimethylsilyloxy)-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
|
33526-41-9
|
C26H44O3Si2
|
|
(4S,5S)-4,10,13-trimethyl-17-(6-methylhept-5-en-2-yl)-2,3,4,5,6,7,11,12,14, 15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
|
7448-03-5
|
C28H46O
|
|
S,S'-TRIMETHYLENEBIS(METHANETHIOSULFONATE)
|
|
C5H12O4S4
|
|
|
4-[(1S,2S)-1,3,3-Trimethyl-1-[[(5R)-2-hydroxy-5-methyl-5-[(R)-1,2-dihydroxyethyl]tetrahydrofuran]-2-yl]cyclohexan-2-yl]butan-3-one
|
|
|
|
|
[(20S,24S)-16β,20,24-Trihydroxy-25-(6-deoxy-α-L-mannopyranosyl)-9β,19-cyclolanostan-3β-yl]2-O-(β-D-glucopyranosyl)-β-D-glucopyranoside
|
|
|
|
|
(1S,4S)-1,7,7-Trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2α-ol
|
|
|
|
|
(1S,2β,5S)-3,3,7β-Trimethyl-4,9-dioxatricyclo[3.3.1.02,7]nonane
|
|
|
|
|
[7S,9S,(+)]-9-[[3-[(Trifluoroacetyl)amino]-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl]oxy]-7-acetyl-5,7,10-trihydroxy-2-trimethylsilyl-6,7,8,9-tetrahydroanthra[2,3-b]thiophene-4,11-dione
|
|
|
|
|
(13α,14S,17S)-1α,11β,12α-Triacetoxy-21,23-epoxy-14-hydroxy-4a,4a-dimethyl-3,15-dioxo-A-homo-24-nor-4-oxa-6,7-seco-5α-chola-7,20,22-triene-6-carboxylic acid methyl ester
|
77902-48-8
|
|
|
|
(6S,8S)-6,8-Tridecanediol
|
|
|
|
|
SS Tube Adapter 1/4-28 Male Tube, 1/4in. OD Tube
|
|
|
|
|
St Jude's regimen
|
|
|
|
|
SstT protein, P. gingivalis
|
|
|
|
|
STK1 kinase
|
|
|
|
|
STK2 kinase
|
|
|
|
|
subalin
|
|
|
|
(S)-Sulconazole
|
180185-78-8
|
|
|
S-SULFO-DL-CYSTEINE-2,3,3-D3
|
|
C3H4D3NO5S2
|
|
S-sulfohomocysteine
|
28715-19-7
|
|
|
|
S-sulfocysteine synthase
|
|
|
|
(S)-Sulfinpyrazone
|
159000-48-3
|
|
|
[35S] SULFURIC ACID
|
|
H2O4S
|
|
S-SULFO-L-CYSTEINE SODIUM SALT
|
1637-71-4
|
C3H7NO5S2
|
|
|
(5S)-3-[4-Sulfamoylphenyl]-5α-(aminomethyl)oxazolidin-2-one
|
|
|
|
|
[S,(+)]-3-Sulfovaleric acid
|
|
|
|
|
(5S)-3-[4-Sulfamoylphenyl]-5β-(hydroxymethyl)oxazolidin-2-one
|
|
|
|
|
[S,(+)]-2-Sulfohexanoic acid
|
|
|
|
|
[S,(-)]-4-Sulfovaleric acid
|
|
|
|
|
[S,(-)]-Sulfosuccinic acid
|
|
|
|
|
[S,(+)]-α-Sulfobenzeneacetic acid
|
|
|
|
|
S-Sulfonato-Cys-OH
|
|
|
|
|
[S,(+)]-2-Sulfovaleric acid
|
|
|
|
|
(5S)-3-[4-Sulfamoylphenyl]-5β-(chloromethyl)oxazolidin-2-one
|
|
|
|
|
[S,(-)]-2-Sulfosuccinamidic acid
|
|
|
|
|
[S,(-)]-2-Sulfopropionic acid
|
|
|
|
|
[S,(+)]-2-(Sulfo)propionic acid diammonium salt
|
|
|
|
|
(1S,4β)-1-(Sulfomethyl)-7,7-dimethylbicyclo[2.2.1]heptane-2-one
|
|
|
|
|
Suba-Seal #37 (fits female 19/22 joint)
|
|
|
|
|
Suba-Seal #25 (fits female 14/20 joint)
|
|
|
|
|
SUBA SEAL WHITE-RUBBER SEPTA FIT &
|
|
|
|
|
Suba-SealTM mixed set
|
|
|
|
|
Suba-Seal #33 (fits Schlenk tube with male 24/40 joint)
|
|
|
|
|
Suba-Seal #49
|
|
|
|
|
Suba-Seal #57 (fits female 29/42 joint)
|
|
|
|
|
Suba-Seal #45 (fits female 24/40 joint)
|
|
|
|
subathizone
|
121-55-1
|
C10H13N3O2S2
|
|
|
SUB-CELLULAR FRACTION SPECIFIC BLOT, MOUSE LIVER
|
|
|
|
|
SUBCELLULARSTUDIES
|
|
|
|
|
(4S,6S)-1-Undecene-4,6-diol
|
|
|
|
|
(5S,7S)-1,10-Undecadiene-5,7-diol
|
|
|
|
subecholine
|
3810-71-7
|
|
|
Subendazole
|
54340-66-8
|
C10H5Cl3N4S3
|
|
|
suanzaorentang
|
|
|
|
|
SUANZAOREN
|
|
|
|
|
Suberic acid-2,2,7,7-d4 bis (3-sulfo-N-hydroxysuccinimide ester) disodium salt
|
|
C16D4H14N2Na2O14S2
|
|
|
Suberanilic Acid
|
|
|
|
|
Suberic acid ion(-2)
|
|
C8H12O4-2
|
|
Suberic acid
|
505-48-6
|
C8H14O4
|
|
|
(S)-Styrene 0xide
|
|
|
|
SUBERYL-2,2,7,7-D4-GLYCINE
|
|
C10H11D4NO4
|
|
SUBERIC ACID DI(2-ETHYLHEXYL) ESTER
|
5238-22-2
|
C24H46O4
|
|
SUBERIC ACID MONOMETHYL ESTER
|
3946-32-5
|
C9H16O4
|
|
(S)-Styrene oxide
|
20780-54-5
|
C8H8O
|
|
SUBEROSIN
|
|
C15H16O3
|
|
|
suberin
|
8072-95-5
|
|
|
|
suberosol
|
|
|
|
SUBERYLGLYCINE-2,2-D2
|
|
C10H13D2NO4
|
|
SUBERIC DIHYDRAZIDE
|
20247-84-1
|
C8H18N4O2
|
|
|
subergorgic acid
|
|
|
|
|
suberitine
|
|
|
|
|
SubericAmine
|
|
|
|
|
SUBERECT SPATHOLOBUS STEM P.E.
|
|
|
|
Suberic acid nitrile
|
|
C8H12N2
|
|
|
Suberect Spatholobus Stem
|
|
|
|
(SUBEROYLBIS(OXYETHYLENE))BIS(TRIMETHYLAMMONIUMIODIDE)
|
|
C18H38I2N2O4
|
|
|
suberylamine
|
|
C7H13NH2
|
|
SUBEROSIN
|
581-31-7
|
C15H16O3
|
|
Suberoylanilide-D5 Hydroxamic Acid
|
|
C14H20N2O3
|
|
|
SUBEROSIS
|
|
|
|
|
SUBERAMIDE,N,N,N',N'-TETRAMETHYL-
|
|
|
|
|
suberedamine A
|
|
|
|
suberoylbisphosphonic acid
|
139339-85-8
|
|
|
|
suberogorgin
|
110043-85-1
|
|
|
|
suberyldithiocholine
|
|
|
|
|
suberedamine B
|
|
|
|
|
Suberoylanilide-D5 Hydroxamic Acid b-D-Glucuronide
|
|
C20H23N2O9D5
|
|
SUBERYLDICHOLINE DICHLORIDE
|
100930-12-9
|
C18H38Cl2N2O4
|
|
Vorinostat
|
149647-78-9
|
C14H20N2O3
|
|
SUBERYLDICHOLINE DIIODIDE
|
7262-79-5
|
C18H38I2N2O4
|
|
Suberoylanilide Hydroxamic Acid b-D-Glucuronide
|
863456-50-2
|
C20H28N2O9
|
|
SUBEROYL CHLORIDE
|
10027-07-3
|
C8H12Cl2O2
|